stockrowLiquidia Corporation (LQDA) vs Prestige Consumer Healthcare Inc. (PBH)
- Liquidia Corporation LQDA 44.69 −5.68%
- Prestige Consumer Healthcare Inc. PBH 44.63 −16.23%
Liquidia Corporation and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Liquidia Corporation is the larger, with a market value of $4.0B against $2.1B — 1.9× the size. Prestige Consumer Healthcare Inc. trades at the lower P/E: 13.7× against 28.5×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 5.10%. Liquidia Corporation has the higher net margin (30.7% vs 13.3%) and the higher return on invested capital (121.1% vs 9.59%). Across the 22 metrics below, Liquidia Corporation leads on 11 and Prestige Consumer Healthcare Inc. on 11.
Valuation
Profitability
| Metric | LQDA | PBH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 92.54% | 52.47% | 53.51% |
| Operating margin | 37.39% | 24.95% | 0.00% |
| Net margin | 30.74% | 13.29% | (2.45%) |
| Free cash flow margin | 33.42% | 18.35% | 0.00% |
| Return on equity | 131.82% | 8.23% | (0.80%) |
| Return on assets | 35.57% | 3.80% | (1.67%) |
| Return on invested capital | 121.05% | 9.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack